Hannachi Nadji, Mariotti Antoine, Gueddari Nabila El, Camoin-Jau Laurence
Département de pharmacie, Faculté de Médecine, Université Ferhat Abbas Sétif I, Sétif 19000, Algerie.
Aix Marseille Univ, APHM, MEPHI, IHU méditerranée infection, Marseille, France.
Int J Cardiol Heart Vasc. 2025 Aug 5;60:101760. doi: 10.1016/j.ijcha.2025.101760. eCollection 2025 Oct.
Thrombocytopenia, a condition characterized by low platelet counts, is recognized as a risk factor in various infectious diseases, but it is not commonly included in prognostic scoring systems for infective endocarditis (IE). This -analysis aimed to assess the relationship between thrombocytopenia and mortality in patients with IE. The study included 25 observational studies (21 retrospective and 4 prospective), covering a total of 110,411 patients diagnosed with IE. The primary outcome was in-hospital mortality associated with thrombocytopenia. Secondary outcomes included the mean difference in platelet counts between survivors and deceased patients, as well as long-term mortality. The results demonstrated that patients with thrombocytopenia had significantly higher in-hospital mortality (Odds Ratio [OR]: 1.99; 95 % Confidence Interval [CI]: 1.72-2.31; < 0.00001). Additionally, patients who died during hospitalization had significantly lower platelet counts compared to survivors (Mean Difference [MD]: -36,750/µL; 95 % CI: -52,570 to -20,920; < 0.00001). Long-term mortality was also elevated in thrombocytopenic patients (Hazard Ratio [HR]: 2.08; 95 % CI: 1.29-3.34; = 0.002). These findings suggest that thrombocytopenia is significantly associated with both in-hospital and long-term mortality in patients with IE. The notable reduction in platelet counts among deceased patients further emphasizes its prognostic significance. The study highlights the need to consider thrombocytopenia in future prognostic models for IE. However, caution is advised when interpreting these results, and additional research is necessary to confirm these associations.
血小板减少症是一种以血小板计数低为特征的病症,被认为是多种传染病的危险因素,但在感染性心内膜炎(IE)的预后评分系统中通常未被纳入。本分析旨在评估血小板减少症与IE患者死亡率之间的关系。该研究纳入了25项观察性研究(21项回顾性研究和4项前瞻性研究),共涵盖110411例被诊断为IE的患者。主要结局是与血小板减少症相关的住院死亡率。次要结局包括存活患者和死亡患者之间血小板计数的平均差异以及长期死亡率。结果表明,血小板减少症患者的住院死亡率显著更高(比值比[OR]:1.99;95%置信区间[CI]:1.72 - 2.31;P < 0.00001)。此外,与存活患者相比,住院期间死亡的患者血小板计数显著更低(平均差异[MD]:-36750/µL;95% CI:-52570至-20920;P < 0.00001)。血小板减少症患者的长期死亡率也有所升高(风险比[HR]:2.08;95% CI:1.29 - 3.34;P = 0.002)。这些发现表明,血小板减少症与IE患者的住院死亡率和长期死亡率均显著相关。死亡患者血小板计数的显著降低进一步强调了其预后意义。该研究强调了在未来IE的预后模型中需要考虑血小板减少症。然而,在解释这些结果时应谨慎,还需要进一步的研究来证实这些关联。